Optimize Financial’s Organon & Co OGN Stock Holding History

Optimize Financial’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,316	Closed	-$154K	–	268
2024 Q4	$154K	Buy	+10,316	New	+$168K	0.12%	223

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optimize Financial's OGN Position: Q1 2025 in Review

Optimize Financial sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 10,316 shares — an estimated $154K sold.

Optimize Financial first reported a position in OGN in Q4 2024 and held it in 1 quarter. The position peaked at $154K in Q4 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

Optimize Financial reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
Optimize Financial sold 10,316 Organon & Co shares in Q1 2025, an estimated $154K.
Optimize Financial first reported a position in Organon & Co in Q4 2024 and held it in 1 quarter.
Optimize Financial's Organon & Co position peaked at $154K in Q4 2024.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Optimize Financial's 13F filing for Q1 2025, filed 14 May 2025.